{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T17:53:21Z","timestamp":1767117201425},"reference-count":100,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.biopsych.2013.06.003","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T13:15:19Z","timestamp":1374758119000},"page":"534-541","source":"Crossref","is-referenced-by-count":66,"title":["Genetics of Alzheimer\u2019s Disease in Caribbean Hispanic and African American Populations"],"prefix":"10.1016","volume":"75","author":[{"given":"Christiane","family":"Reitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Mayeux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2013.06.003_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00002512-199915050-00004","article-title":"Worldwide prevalence and incidence of dementia","volume":"15","author":"Fratiglioni","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.biopsych.2013.06.003_bib2","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"issue":"suppl 3","key":"10.1016\/j.biopsych.2013.06.003_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2006-9S338","article-title":"Segregation of a missense mutation in the amyloid beta-protein precursor gene with familial Alzheimer\u2019s disease","volume":"9","author":"Goate","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2013.06.003_bib4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2013.06.003_bib5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2013.06.003_bib6","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2013.06.003_bib7","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.55.7.964","article-title":"Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: The Rotterdam Study","volume":"55","author":"Slooter","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2013.06.003_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000334607","article-title":"Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4\/4) among patients diagnosed with Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"38","author":"Ward","year":"2012","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.biopsych.2013.06.003_bib10","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2013.06.003_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2013.06.003_bib12","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2013.06.003_bib13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2013.06.003_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.22308","article-title":"SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer\u2019s disease risk","volume":"69","author":"Reitz","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2013.06.003_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2013.06.003_bib17","doi-asserted-by":"crossref","first-page":"M117","DOI":"10.1093\/gerona\/52A.2.M117","article-title":"Heritability for Alzheimer\u2019s disease: The study of dementia in Swedish twins","volume":"52","author":"Gatz","year":"1997","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.biopsych.2013.06.003_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archneur.60.2.185","article-title":"Incidence of Alzheimer disease in a biracial urban community: Relation to apolipoprotein E allele status","volume":"60","author":"Evans","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/archneur.59.4.594","article-title":"Association between apolipoprotein E genotype and Alzheimer disease in African American subjects","volume":"59","author":"Graff-Radford","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archneur.63.3.431","article-title":"Association of apolipoprotein E genotype and Alzheimer disease in African Americans","volume":"63","author":"Murrell","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/WNL.56.1.49","article-title":"Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan","volume":"56","author":"Tang","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2013.06.003_bib22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.279.10.751","article-title":"The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics","volume":"279","author":"Tang","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2013.06.003_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jalz.2012.02.001","volume":"8","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2013.06.003_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/jama.287.3.329","article-title":"Risk of dementia among white and African American relatives of patients with Alzheimer disease","volume":"287","author":"Green","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2013.06.003_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.53.2.321","article-title":"APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study","volume":"53","author":"Breitner","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2013.06.003_bib26","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2013.06.003_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ana.410390110","article-title":"Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer\u2019s disease","volume":"39","author":"Gomez-Isla","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/jnnp.61.6.580","article-title":"Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer\u2019s disease","volume":"61","author":"Holmes","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2013.06.003_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1996.tb32592.x","article-title":"Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer\u2019s disease","volume":"802","author":"Hyman","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2013.06.003_bib30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF00900498","article-title":"Apolipoprotein E type 4 allele and Alzheimer\u2019s disease: Effect on age at onset and relative risk in different age groups","volume":"243","author":"Kurz","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib31","first-page":"251","article-title":"Apolipoprotein E and Alzheimer\u2019s disease: Strength of association is related to age at onset","volume":"7","author":"Murman","year":"1996","journal-title":"Dementia"},{"key":"10.1016\/j.biopsych.2013.06.003_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","article-title":"Apolipoprotein E polymorphism and Alzheimer\u2019s disease","volume":"342","author":"Poirier","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2013.06.003_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/21548331.1997.11443525","article-title":"Alzheimer\u2019s disease: the genetics of risk","volume":"32","author":"Roses","year":"1997","journal-title":"Hosp Pract (Minneap)"},{"key":"10.1016\/j.biopsych.2013.06.003_bib34","first-page":"574","article-title":"Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City","volume":"58","author":"Tang","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2013.06.003_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JAD-2002-4307","article-title":"Non-familial Alzheimer\u2019s disease is mainly due to genetic factors","volume":"4","author":"Ashford","year":"2002","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2013.06.003_bib36","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2013.06.003_bib37","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2013.06.003_bib38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","article-title":"Apolipoprotein E in sporadic Alzheimer\u2019s disease: Allelic variation and receptor interactions","volume":"11","author":"Rebeck","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2013.06.003_bib39","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","article-title":"Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer\u2019s disease","volume":"96","author":"Bales","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2013.06.003_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","article-title":"Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition","volume":"17","author":"Bales","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2013.06.003_bib41","first-page":"1387","article-title":"Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice","volume":"152","author":"Kindy","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/372092a0","article-title":"Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments","volume":"372","author":"Ma","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2013.06.003_bib43","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI117407","article-title":"Apolipoprotein E associates with beta amyloid peptide of Alzheimer\u2019s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3","volume":"94","author":"Sanan","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biopsych.2013.06.003_bib44","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2013.06.003_bib45","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI6179","article-title":"Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer\u2019s disease","volume":"103","author":"Holtzman","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biopsych.2013.06.003_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.1994.1044","article-title":"Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol","volume":"126","author":"Sparks","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","article-title":"Hypercholesterolemia accelerates the Alzheimer\u2019s amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2013.06.003_bib48","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1074\/jbc.271.8.4436","article-title":"Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein","volume":"271","author":"Bodovitz","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2013.06.003_bib49","doi-asserted-by":"crossref","first-page":"16576","DOI":"10.1074\/jbc.273.26.16576","article-title":"Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol","volume":"273","author":"Howland","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2013.06.003_bib50","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/archneur.61.9.1434","article-title":"APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals","volume":"61","author":"Tycko","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib51","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/jama.2013.2973","article-title":"Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4,and the risk of late-onset Alzheimer disease in African Americans","volume":"309","author":"Reitz","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2013.06.003_bib52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/tpj.2009.69","article-title":"A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer\u2019s disease","volume":"10","author":"Roses","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.biopsych.2013.06.003_bib53","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archneurol.2011.155","article-title":"Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease","volume":"68","author":"Cruchaga","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib54","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/archneurol.2012.2052","article-title":"Comprehensive search for Alzheimer disease susceptibility loci in the APOE region","volume":"69","author":"Jun","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib55","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.1997.03550150041033","article-title":"Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12","volume":"278","author":"Pericak-Vance","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2013.06.003_bib56","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jama.280.7.614","article-title":"Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity","volume":"280","author":"Rogaeva","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2013.06.003_bib57","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1086\/302828","article-title":"Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: Potential genetic and phenotypic heterogeneity","volume":"66","author":"Scott","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2013.06.003_bib58","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.281.6.513","article-title":"Further evidence linking late-onset Alzheimer disease with chromosome 12","volume":"281","author":"Scott","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2013.06.003_bib59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1086\/324773","article-title":"Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics","volume":"70","author":"Mayeux","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2013.06.003_bib60","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/sj.mp.4001538","article-title":"Fine mapping of 10q and 18q for familial Alzheimer\u2019s disease in Caribbean Hispanics","volume":"9","author":"Lee","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.06.003_bib61","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10048-008-0122-8","article-title":"Further examination of the candidate genes in chromosome 12p13 locus for late-onset Alzheimer disease","volume":"9","author":"Lee","year":"2008","journal-title":"Neurogenetics"},{"key":"10.1016\/j.biopsych.2013.06.003_bib62","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/archneur.63.11.1591","article-title":"Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease","volume":"63","author":"Lee","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib63","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ajmg.b.30257","article-title":"A genome-wide linkage analysis of dementia in the Amish","volume":"141B","author":"Hahs","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.biopsych.2013.06.003_bib64","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1212\/WNL.57.9.1663","article-title":"Genome-wide linkage disequilibrium mapping of late-onset Alzheimer\u2019s disease in Finland","volume":"57","author":"Hiltunen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2013.06.003_bib65","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/8.2.237","article-title":"A full genome scan for late onset Alzheimer\u2019s disease","volume":"8","author":"Kehoe","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2013.06.003_bib66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0531-5565(00)00196-0","article-title":"Identification of novel genes in late-onset Alzheimer\u2019s disease","volume":"35","author":"Pericak-Vance","year":"2000","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib67","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jama.280.7.619","article-title":"Genetic studies on chromosome 12 in late-onset Alzheimer disease","volume":"280","author":"Wu","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2013.06.003_bib68","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1126\/science.290.5500.2304","article-title":"Susceptibility locus for Alzheimer\u2019s disease on chromosome 10","volume":"290","author":"Myers","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2013.06.003_bib69","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1126\/science.290.5500.2303","article-title":"Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer\u2019s disease pedigrees","volume":"290","author":"Ertekin-Taner","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2013.06.003_bib70","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1126\/science.290.5500.2302","article-title":"Evidence for genetic linkage of Alzheimer\u2019s disease to chromosome 10q","volume":"290","author":"Bertram","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2013.06.003_bib71","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1073\/pnas.95.6.3275","article-title":"Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation","volume":"95","author":"Hughes","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2013.06.003_bib72","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000109765","article-title":"The heritability of abstract reasoning in Caribbean Latinos with familial Alzheimer disease","volume":"24","author":"Johnson","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.biopsych.2013.06.003_bib73","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/01.WNL.0000106461.96637.AC","article-title":"Genetic influences on memory performance in familial Alzheimer disease","volume":"62","author":"Lee","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2013.06.003_bib74","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archneur.64.4.501","article-title":"The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort","volume":"64","author":"Lee","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib75","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1943","article-title":"The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease","volume":"39","author":"Rogaeva","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2013.06.003_bib76","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archneurol.2010.346","article-title":"Meta-analysis of the association between variants in SORL1 and Alzheimer disease","volume":"68","author":"Reitz","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib77","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/archneurol.2010.292","article-title":"Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals","volume":"68","author":"Lee","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib78","doi-asserted-by":"crossref","first-page":"e50354","DOI":"10.1371\/journal.pone.0050354","article-title":"Genetic variants in the Fat and Obesity Associated (FTO) gene and risk of Alzheimer\u2019s disease","volume":"7","author":"Reitz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2013.06.003_bib79","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/ng2048","article-title":"Variation in FTO contributes to childhood obesity and severe adult obesity","volume":"39","author":"Dina","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2013.06.003_bib80","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2337\/db10-1340","article-title":"FTO, type 2 diabetes, and weight gain throughout adult life: A meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies","volume":"60","author":"Hertel","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.biopsych.2013.06.003_bib81","doi-asserted-by":"crossref","first-page":"e18939","DOI":"10.1371\/journal.pone.0018939","article-title":"A genome-wide association study on obesity and obesity-related traits","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2013.06.003_bib82","doi-asserted-by":"crossref","first-page":"8404","DOI":"10.1073\/pnas.0910878107","article-title":"A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly","volume":"107","author":"Ho","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2013.06.003_bib83","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archneurol.2011.2463","article-title":"Effect of genetic variation in LRRTM3 on risk of Alzheimer disease","volume":"69","author":"Reitz","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib84","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1534\/g3.111.000869","article-title":"Genome-wide survey of large rare copy number variants in Alzheimer\u2019s disease among Caribbean hispanics","volume":"2","author":"Ghani","year":"2012","journal-title":"G3 (Bethesda)"},{"issue":"199","key":"10.1016\/j.biopsych.2013.06.003_bib85","first-page":"e113","article-title":"Association between variants in IDE-KIF11-HHEX and plasma amyloid beta levels","volume":"33","author":"Reitz","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2013.06.003_bib86","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/humu.10282","article-title":"Genetic variation in a haplotype block spanning IDE influences Alzheimer disease","volume":"22","author":"Prince","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.biopsych.2013.06.003_bib87","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/humu.20016","article-title":"Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease","volume":"23","author":"Ertekin-Taner","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.biopsych.2013.06.003_bib88","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1007527721160","article-title":"Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains","volume":"25","author":"Perez","year":"2000","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biopsych.2013.06.003_bib89","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2013.06.003_bib90","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00109-009-0540-6","article-title":"Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes","volume":"87","author":"Rudovich","year":"2009","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.biopsych.2013.06.003_bib91","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.286.18.2257","article-title":"A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families","volume":"286","author":"Athan","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2013.06.003_bib92","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10048-002-0136-6","article-title":"A novel presenilin 1 mutation (L174 M) in a large Cuban family with early onset Alzheimer disease","volume":"4","author":"Bertoli Avella","year":"2002","journal-title":"Neurogenetics"},{"key":"10.1016\/j.biopsych.2013.06.003_bib93","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/archneurol.2011.646","article-title":"A comprehensive genetic association study of Alzheimer disease in African Americans","volume":"68","author":"Logue","year":"2011","journal-title":"Arch Neurol"},{"issue":"557","key":"10.1016\/j.biopsych.2013.06.003_bib94","first-page":"e551","article-title":"Association of common KIBRA variants with episodic memory and AD risk","volume":"32","author":"Burgess","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2013.06.003_bib95","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.1129837","article-title":"Common Kibra alleles are associated with human memory performance","volume":"314","author":"Papassotiropoulos","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2013.06.003_bib96","doi-asserted-by":"crossref","unstructured":"Akomolafe A, Lunetta KL, Erlich PM, Cupples LA, Baldwin CT, Huyck M, et al.; MIRAGE Study Group (2006): Genetic association between endothelial nitric oxide synthase and Alzheimer disease. Clin Genet 70:49-56","DOI":"10.1111\/j.1399-0004.2006.00638.x"},{"key":"10.1016\/j.biopsych.2013.06.003_bib97","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/hmg\/ddi428","article-title":"Polymorphisms in the PON gene cluster are associated with Alzheimer disease","volume":"15","author":"Erlich","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2013.06.003_bib98","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.exger.2011.09.005","article-title":"The association of genetic variants in interleukin-1 genes with cognition: Findings from the cardiovascular health study","volume":"46","author":"Benke","year":"2011","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.biopsych.2013.06.003_bib99","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.neurobiolaging.2009.02.014","article-title":"Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families","volume":"32","author":"Cuenco","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2013.06.003_bib100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.23644","article-title":"Multiple loci influencing hippocampal degeneration identified by genome scan","volume":"72","author":"Melville","year":"2012","journal-title":"Ann Neurol"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322313005477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322313005477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T09:53:13Z","timestamp":1563529993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322313005477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":100,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0006322313005477"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2013.06.003","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}